152 related articles for article (PubMed ID: 7948571)
1. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy.
Wingard JR
Clin Infect Dis; 1994 Aug; 19 Suppl 1():S49-53. PubMed ID: 7948571
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
4. Resistance of Candida species to antifungal agents used in the treatment of onychomycosis: a review of current problems.
Evans EG
Br J Dermatol; 1999 Nov; 141 Suppl 56():33-5. PubMed ID: 10730912
[TBL] [Abstract][Full Text] [Related]
5. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
6. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
7. Oral candidal speciation, virulence and antifungal susceptibility in type 2 diabetes mellitus.
Patel PN; Sah P; Chandrashekar C; Vidyasagar S; Venkata Rao J; Tiwari M; Radhakrishnan R
Diabetes Res Clin Pract; 2017 Mar; 125():10-19. PubMed ID: 28131069
[TBL] [Abstract][Full Text] [Related]
8. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
10. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Shokri H; Sharifzadeh A
J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
[TBL] [Abstract][Full Text] [Related]
11. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
13. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibilities of Candida species isolated from urine culture.
Toka Özer T; Durmaz S; Yula E
J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
[TBL] [Abstract][Full Text] [Related]
15. Resistance to antifungal agents in the critical care setting: problems and perspectives.
Martins MD; Rex JH
New Horiz; 1996 Aug; 4(3):338-44. PubMed ID: 8856751
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Skrodeniene E; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
[TBL] [Abstract][Full Text] [Related]
17. [Antifungal susceptibility of Candida species isolated from patient with invasive fungal peritonitis and investigation on clinical breakpoints of itraconazole].
Yamagishi Y; Terada M; Ohki E; Mikamo H
Jpn J Antibiot; 2009 Oct; 62(5):415-34. PubMed ID: 20055119
[TBL] [Abstract][Full Text] [Related]
18. Azole resistance in neonatal intensive care units in Argentina.
Giusiano G; Mangiaterra M; Rojas F; Gómez V
J Chemother; 2005 Jun; 17(3):347-50. PubMed ID: 16038532
[TBL] [Abstract][Full Text] [Related]
19. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
[TBL] [Abstract][Full Text] [Related]
20. Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.
Fortún J; López-San Román A; Velasco JJ; Sánchez-Sousa A; de Vicente E; Nuño J; Quereda C; Bárcena R; Monge G; Candela A; Honrubia A; Guerrero A
Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):314-8. PubMed ID: 9177967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
